Authors
Brian C Callaghan, Hsinlin T Cheng, Catherine L Stables, Andrea L Smith, Eva L Feldman
Publication date
2012/6/1
Source
The lancet NEUROLOGY
Volume
11
Issue
6
Pages
521-534
Publisher
Elsevier
Description
Diabetic peripheral neuropathy is a prevalent, disabling disorder. The most common manifestation is distal symmetrical polyneuropathy (DSP), but many patterns of nerve injury can occur. Currently, the only effective treatments are glucose control and pain management. While glucose control substantially decreases the development of neuropathy in those with type 1 diabetes, the effect is probably much smaller in those with type 2 diabetes. Evidence supports the use of specific anticonvulsants and antidepressants for pain management in patients with diabetic peripheral neuropathy. However, the lack of disease-modifying therapies for diabetic DSP makes the identification of new modifiable risk factors essential. Growing evidence supports an association between components of the metabolic syndrome, including prediabetes, and neuropathy. Studies are needed to further explore this association, which has …
Total citations
Scholar articles
BC Callaghan, HT Cheng, CL Stables, AL Smith… - The lancet NEUROLOGY, 2012